Researchers at Sbarro Health Research Organization have discovered a new mechanism for INK4/ARF protein inactivation in Burkitt's lymphoma. The study suggests that reactivating tumor suppressor genes p16 and p14 could lead to the inhibition of cell proliferation and induction of apoptosis, offering potential new treatment avenues.
A new study reveals that the CCCTC-binding factor (CTCF) and BORIS proteins directly regulate Rb2/p130 gene expression in lung cells. The findings show that small lung cancer cells exhibit low expression levels of Rb2/p130, while non-small lung cancer cells are overexpressed compared to normal lung cells.
A new study published in Molecular Pain found that a single injection of morphine can strongly reduce testosterone levels in the brain and plasma of male rats. The study's findings are particularly important as testosterone is essential for various bodily functions, including cognitive functions and bone structure remodeling.
The incidence of acute myocardial infarction sharply increased among young Italian women between 2001 and 2005, with a total of over 118,000 reported cases in 2005. The study also found that the increase was higher in younger women aged 45-64 years.
Researchers discovered new pyrimidine compounds that target Src tyrosine kinases in medulloblastoma cells, showing reduced cell proliferation and tumor progression. These compounds may offer a more effective treatment option for childhood brain cancer, with potential synergistic effects when combined with chemotherapy.
A new study published in Journal of Clinical Oncology found that pazopanib slowed the progression of advanced renal cell carcinoma, a form of kidney cancer, in patients by 54%. The drug targets multiple pathways within cancer cells, inhibiting blood vessel development. Common side effects include diarrhea, hypertension, and weight loss.
Researchers found reduced p16INK4a RNA expression and demethylation of the gene in 55% of patients, suggesting a novel susceptibility marker. Low to moderate 16INK4A protein expression was also detected in 45% of retinoblastoma tumor specimens.
A new prognostic biomarker has been identified in cases of soft tissue sarcoma (STS), suggesting a direct relationship between pRb2/p130 expression and clinical outcome. Lower levels of the gene are associated with higher risk of recurrence and death from STS, offering potential for improved treatment strategies.